Skip to main content
IFUS logo

Impact Fusion International, Inc. (IFUS) Stock Price & Analysis

Impact Fusion International, Inc. (IFUS) — price $0.035 (-3.87%), as of the Oct 2, 2026 trading session; market cap $20.2M.

Educational signal · not a buy or sell recommendation · How to read this

$0.035 −$0.00141 (-3.87%) Market Cap $20.2M

Impact Fusion International, Inc. · IFUS

Impact Fusion International, Inc. develops and markets proprietary health and wellness products for humans and animals globally. The company's portfolio includes nutritional supplements like Nutri-Mastic and herbal beverages under brands such as Mastic Blast Beverage, targeting digestive, immune, and energy support.

Price as of Oct 2, 2026

Key Statistics

MoonshotScore is not published for this security.

Price & valuation

As of
MeasureValue
Latest provided price$0.035
Change on the day-3.87%
52-week range$0.005 – $0.054
Market capitalisation$20.2M
Price / earnings (trailing)323.55
Shares traded on the day131.5K

Price & events

Other perspectives

Council score for Impact Fusion International (IFUS): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

3 lenses, 3 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Oct 4, 2026

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Strong
Gross Margin Strong

Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Oct 5, 2026, except a card that shows its own read date.

Watch the IFUS film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is Impact Fusion International (IFUS), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Impact Fusion International, Inc. (IFUS) is the company analyzed here. It employs 6 people and is led by Marc A. Walther. In Q3 FY2026 it reported revenue of $54,995 and net income of $24,993. The market values it at $20.2M.

2 · Latest results

What do the latest results show for Impact Fusion International (IFUS)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $54,995.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$54,995$24,993$0.0000 (diluted)
Q2 FY2026$25,378$6,781$0.0000 (diluted)
Q1 FY2026$41,471$12,360$0.0000 (diluted)
Q4 FY2025$65,305$20,670$0.0000 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Impact Fusion International (IFUS)?

Short answer

The distress and quality screens read Altman Z 15.71 · Piotroski F 4. Trailing ratios: ROE 45.9% · ROA 5.6% · current ratio 23.33 · earnings yield 0.3% · free-cash-flow yield -0.9%.

What has been published about Impact Fusion International (IFUS)?

Read these with our analysis →

What Investors Ask About Impact Fusion International (IFUS)

These answers are editorial: 1 of these 8 answers is drawn from the IFUS research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is IFUS a good stock to buy?

Stock Expert AI does not rate IFUS buy, sell or hold. Impact Fusion International, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the IFUS stock price today?

The last price recorded on this page for Impact Fusion International, Inc. (IFUS) is $0.035, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What does Impact Fusion International, Inc. do?

Impact Fusion International, Inc. is engaged in the invention, development, and global marketing of proprietary health and wellness products for both humans and animals. It also offers herbal health support beverages under the Mastic Blast Beverage brand.

What are the key factors to evaluate for IFUS?

Evaluate IFUS on fundamentals, analyst consensus, and risk factors. P/E: 323.55x. The global e-commerce market for health and wellness products has seen substantial growth, accelerated by shifts in consumer purchasing habits. Not financial advice.

How frequently does IFUS data refresh on this page?

IFUS's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven IFUS's recent stock price performance?

Impact Fusion International, Inc. (IFUS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary product portfolio for human and animal health. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider IFUS overvalued or undervalued right now?

Impact Fusion International, Inc. (IFUS) trades at 323.55x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research IFUS before investing?

Before investing in Impact Fusion International, Inc. (IFUS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources — records for every figure on this page (14 figures)

The 14 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

FMP — 9 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.lastLatest provided price$0.035FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T11:34:18.801Z.
px.changeChange on the day-3.87%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalisation$20.2MFMPFinancial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-04T11:34:18.019Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars−$0.00141FMPFinancial Modeling Prep (FMP) · quote
px.pePrice / earnings (trailing)323.55FMPFinancial Modeling Prep (FMP) · quote
px.volumeShares traded on the day131.5KFMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q3 FY2026$54,995FMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_incomeNet income, Q3 FY2026$24,993FMPFinancial Modeling Prep (FMP) · income statement (quarterly)
fin.q_tableQuarterly income statement4 quarters through Q3 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed

UNRECORDED — 5 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
px.range5252-week range$0.005 – $0.054UNRECORDEDStored company-profile observation — Captured 2026-10-02
id.employeesEmployees6UNRECORDEDStored company-profile observation — Captured 2026-10-02
id.ceoChief executiveMarc A. WaltherUNRECORDEDStored company-profile observation — Captured 2026-10-02
fin.scoresDistress and quality screensAltman Z 15.71 · Piotroski F 4UNRECORDEDStored financial-scores observation — Captured 2026-10-03 · Expired observation
fin.ratiosReturn and yield ratios (trailing twelve months)ROE 45.9% · ROA 5.6% · current ratio 23.33 · earnings yield 0.3% · free-cash-flow yield -0.9%—UNRECORDEDStored key metrics — Date unknown
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.